CN Patent

CN117679397B — 一种布瓦西坦缓释干混悬剂及其制备方法

Assigned to Hubei Yangtze Ruiyi Pharmaceutical Technology Co Ltd · Expires 2025-06-13 · 1y expired

What this patent protects

本发明涉及药物制剂制备技术领域，具体公开了一种布瓦西坦缓释干混悬剂及其制备方法。本发明的布瓦西坦缓释干混悬剂由缓释载药树脂、助悬剂和矫味剂组成。本发明通过离子交换树脂载药后进行缓释包衣制备的布瓦西坦干混悬剂，具有缓释作用，可降低每日给药次数，并且制备成干混悬剂也能克服片剂不易给药，口服溶液携带不方便，注射剂给药方式麻烦等问题。

USPTO Abstract

本发明涉及药物制剂制备技术领域，具体公开了一种布瓦西坦缓释干混悬剂及其制备方法。本发明的布瓦西坦缓释干混悬剂由缓释载药树脂、助悬剂和矫味剂组成。本发明通过离子交换树脂载药后进行缓释包衣制备的布瓦西坦干混悬剂，具有缓释作用，可降低每日给药次数，并且制备成干混悬剂也能克服片剂不易给药，口服溶液携带不方便，注射剂给药方式麻烦等问题。

Drugs covered by this patent

Patent Metadata

Patent number: CN117679397B
Jurisdiction: CN
Classification: —
Expires: 2025-06-13
Drug substance claim: No
Drug product claim: No
Assignee: Hubei Yangtze Ruiyi Pharmaceutical Technology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.